ALXP
ALBIO
Market cap17mUSD
Oct 28, Last price
0.84EUR
1D
0.72%
1Q
-7.08%
Jan 2017
-54.10%
IPO
-93.82%
Name
Biosynex SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Biosynex S.A. specializes in the development, manufacture, and worldwide distribution of rapid diagnostic solutions. Their extensive product line includes a variety of quick diagnostic assays, immunoblots, molecular biology tools, and point-of-care devices. These offerings are vital for screening, diagnosis, and prevention across numerous medical fields, such as bacteriology, parasitology, mycology, virology, biochemistry, oncology, and women's health, alongside specific COVID-19 tests and related instruments. Additionally, Biosynex provides consumer products like self-testing kits, personal health monitoring equipment (including thermometers and blood pressure monitors), and a selection of oral care and medical aid supplies. The company serves a diverse client base, including biological and medical analysis laboratories, hospitals, pharmacies, and large retail outlets like hypermarkets and supermarkets. Founded in 1993, Biosynex S.A. is headquartered in Illkirch-Graffenstaden, France.
Related entities
Subsidiaries
BIOSYNEX SWISS SA
Key people
Larry Abensur
Chairman of the Board, Chief Executive Officer · since 2024
Diane Bessin
Director · since 2024
Elie Fraenckel
Director
Thomas Lamy
Deputy Chief Executive Officer, Director · since 2015
Thierry Paper
Deputy Chief Executive Officer - Research and Business Development, Director · since 2015
Headquarters & legal address
22 BOULEVARD SEBASTIEN BRANT
ILLKIRCH-GRAFFENSTADEN 67400
FR
ILLKIRCH-GRAFFENSTADEN 67400
FR
Valuation
Title EUR in thousands, except ratios and share amounts | FY |
|---|---|
| 2025‑12 | |
| Income | |
Revenues | |
Cost of revenue | |
Unusual Expense (Income) | |
NOPBT | |
NOPBT Margin | |
Operating Taxes | |
Tax Rate | |
NOPAT | |
Net income | |
Dividends | |
Dividend yield | |
Proceeds from repurchase of equity | |
BB yield | |
| Debt | |
Debt current | |
Long-term debt | |
Deferred revenue | |
Other long-term liabilities | |
Net debt | |
| Cash flow | |
Cash from operating activities | |
CAPEX | |
Cash from investing activities | |
Cash from financing activities | |
FCF | |
| Balance | |
Cash | |
Long term investments | |
Excess cash | |
Stockholders' equity | |
Invested Capital | |
ROIC | |
ROCE | |
| EV | |
Common stock shares outstanding | |
Price | |
Market cap | |
EV | |
EBITDA | |
EV/EBITDA | |
Interest | |
Interest/NOPBT | |